Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
靶向 BCL11A 的基因疗法可诱导胎儿血红蛋白并降低镰状细胞病患者的镰状血红蛋白
基本信息
- 批准号:10083551
- 负责人:
- 金额:$ 120.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-22 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAllogenicArchitectureAttenuatedAutologousBiocompatible MaterialsBiologicalCellsClinicalDataDiseaseEngraftmentEnrollmentErythrocytesErythroidErythroid CellsFeasibility StudiesFetal HemoglobinFetal ReductionFutureGene TransferGene-ModifiedGenesGlobinGoalsHalf-LifeHealthHematologyHematopoietic Stem Cell TransplantationHematopoietic stem cellsHemoglobinHemoglobinopathiesHumanIncidenceIndividualLaboratoriesLeadLifeMicroRNAsMolecularOutcomePatientsPhenotypeRiskSeveritiesSiblingsSickle CellSickle Cell AnemiaSickle HemoglobinTransgenesTransplantationbasebeta Thalassemiaclinical effectcohortcurative treatmentsdisease phenotypefetalgamma Globingene therapygene transfer vectorgraft failuregraft vs host diseaseimprovedin vivoknock-downmathematical modelmortalitymouse modelmutantphase I trialpolymerizationpre-clinicalpreventsafety and feasibilitysicklingsmall hairpin RNAstem cellstargeted treatmentvector
项目摘要
No abstract provided
未提供摘要
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Magnetic resonance imaging metrics of oxygen extraction fraction: Contradictions or insight into pathophysiological mechanisms?
- DOI:10.1002/ajh.26567
- 发表时间:2022-06-01
- 期刊:
- 影响因子:12.8
- 作者:Stout, Jeffrey N.;Lin, Pei-Yi;Sutin, Jason;Higgins, John;Grant, P. Ellen
- 通讯作者:Grant, P. Ellen
Corrigendum.
- DOI:10.1111/jebm.12410
- 发表时间:2020-08
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.
- DOI:10.1038/s41591-023-02636-6
- 发表时间:2023-12
- 期刊:
- 影响因子:82.9
- 作者:Chapman, Michael Spencer;Cull, Alyssa H.;Ciuculescu, Marioara F.;Esrick, Erica B.;Mitchell, Emily;Jung, Hyunchul;O'Neill, Laura;Roberts, Kirsty;Fabre, Margarete A.;Williams, Nicholas;Nangalia, Jyoti;Quinton, Joanne;Fox, James M.;Pellin, Danilo;Makani, Julie;Armant, Myriam;Williams, David A.;Campbell, Peter J.;Kent, David G.
- 通讯作者:Kent, David G.
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.
- DOI:10.1038/s41467-023-40923-5
- 发表时间:2023-09-20
- 期刊:
- 影响因子:16.6
- 作者:De Souza, Daniel C.;Hebert, Nicolas;Esrick, Erica B.;Ciuculescu, M. Felicia;Archer, Natasha M.;Armant, Myriam;Audureau, Etienne;Brendel, Christian;Di Caprio, Giuseppe;Galacteros, Frederic;Liu, Donghui;Mccabe, Amanda;Morris, Emily;Schonbrun, Ethan;Williams, Dillon;Wood, David K.;Williams, David A.;Bartolucci, Pablo;Higgins, John M.
- 通讯作者:Higgins, John M.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A WILLIAMS其他文献
DAVID A WILLIAMS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A WILLIAMS', 18)}}的其他基金
The role of Septin6 Group in Murine and Human Hematopoiesis
Septin6 组在小鼠和人类造血中的作用
- 批准号:
10718515 - 财政年份:2023
- 资助金额:
$ 120.04万 - 项目类别:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
靶向 BCL11A 的基因疗法可诱导胎儿血红蛋白并降低镰状细胞病患者的镰状血红蛋白
- 批准号:
10179447 - 财政年份:2017
- 资助金额:
$ 120.04万 - 项目类别:
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
靶向 BCL11A 的基因疗法可诱导胎儿血红蛋白并降低镰状细胞病患者的镰状血红蛋白
- 批准号:
9363943 - 财政年份:2017
- 资助金额:
$ 120.04万 - 项目类别:
Gene Therapy for SCID-X1 with Low Dose Busulfan and a SIN-lentiviral Vector
使用低剂量白消安和 SIN 慢病毒载体对 SCID-X1 进行基因治疗
- 批准号:
10827632 - 财政年份:2016
- 资助金额:
$ 120.04万 - 项目类别:
Development of novel selective Rac inhibitors for refractory leukemias
开发治疗难治性白血病的新型选择性 Rac 抑制剂
- 批准号:
9176356 - 财政年份:2016
- 资助金额:
$ 120.04万 - 项目类别:
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
使用低剂量白消安和 SIN 慢病毒载体对 SCID-X1 进行基因治疗
- 批准号:
10207386 - 财政年份:2016
- 资助金额:
$ 120.04万 - 项目类别:
相似海外基金
HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
- 批准号:
10039902 - 财政年份:2022
- 资助金额:
$ 120.04万 - 项目类别:
EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
- 批准号:
21K15925 - 财政年份:2021
- 资助金额:
$ 120.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
- 批准号:
21K08410 - 财政年份:2021
- 资助金额:
$ 120.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
- 批准号:
20K21672 - 财政年份:2020
- 资助金额:
$ 120.04万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
- 批准号:
18K16395 - 财政年份:2018
- 资助金额:
$ 120.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
- 批准号:
17K10951 - 财政年份:2017
- 资助金额:
$ 120.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
- 批准号:
370541 - 财政年份:2017
- 资助金额:
$ 120.04万 - 项目类别:
Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
- 批准号:
16K10863 - 财政年份:2016
- 资助金额:
$ 120.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
- 批准号:
276706135 - 财政年份:2015
- 资助金额:
$ 120.04万 - 项目类别:
Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
- 批准号:
15H04915 - 财政年份:2015
- 资助金额:
$ 120.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




